These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2820085)
1. The effects of perfluoro-n-decanoic acid (PFDA) on rat heart beta-receptors, adenylate cyclase, and fatty acid composition. Pilcher GD; Gutshall DM; Langley AE Toxicol Appl Pharmacol; 1987 Sep; 90(2):198-205. PubMed ID: 2820085 [TBL] [Abstract][Full Text] [Related]
2. The effects of perfluoro-n-decanoic acid in the rat heart. Pilcher GD; Langley AE Toxicol Appl Pharmacol; 1986 Sep; 85(3):389-97. PubMed ID: 3020739 [TBL] [Abstract][Full Text] [Related]
3. Alloxan-induced diabetes reduces beta-adrenergic receptor number without affecting adenylate cyclase in rat ventricular membranes. Ingebretsen CG; Hawelu-Johnson C; Ingebretsen WR J Cardiovasc Pharmacol; 1983; 5(3):454-61. PubMed ID: 6191147 [TBL] [Abstract][Full Text] [Related]
4. Effects of perfluoro-n-decanoic acid on the respiratory activity of isolated rat liver mitochondria. Langley AE J Toxicol Environ Health; 1990; 29(3):329-36. PubMed ID: 2313742 [TBL] [Abstract][Full Text] [Related]
5. Thyroid, bradycardic and hypothermic effects of perfluoro-n-decanoic acid in rats. Langley AE; Pilcher GD J Toxicol Environ Health; 1985; 15(3-4):485-91. PubMed ID: 4032495 [TBL] [Abstract][Full Text] [Related]
6. Perfluoro-n-decanoic acid: induction of peroxisomal beta-oxidation by a fatty acid with dioxin-like toxicity. Harrison EH; Lane JS; Luking S; Van Rafelghem MJ; Andersen ME Lipids; 1988 Feb; 23(2):115-9. PubMed ID: 3367697 [TBL] [Abstract][Full Text] [Related]
7. Effects of perfluorodecanoic acid on thyroid status in rats. Van Rafelghem MJ; Inhorn SL; Peterson RE Toxicol Appl Pharmacol; 1987 Mar; 87(3):430-9. PubMed ID: 3564018 [TBL] [Abstract][Full Text] [Related]
8. Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig. Van Rafelghem MJ; Mattie DR; Bruner RH; Andersen ME Fundam Appl Toxicol; 1987 Oct; 9(3):522-40. PubMed ID: 3692011 [TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase activity, membrane fluidity and fatty acid composition of rat heart in essential fatty acid deficiency. Alam SQ; Alam BS; Ren YF J Mol Cell Cardiol; 1987 May; 19(5):465-75. PubMed ID: 3625782 [TBL] [Abstract][Full Text] [Related]
10. Effect of thyroxine supplementation on the response to perfluoro-n-decanoic acid (PFDA) in rats. Gutshall DM; Pilcher GD; Langley AE J Toxicol Environ Health; 1988; 24(4):491-8. PubMed ID: 3411633 [TBL] [Abstract][Full Text] [Related]
11. The interaction of dietary fatty acid and cholesterol on catecholamine-stimulated adenylate cyclase activity in the rat heart. McMurchie EJ; Patten GS; Charnock JS; McLennan PL Biochim Biophys Acta; 1987 Apr; 898(2):137-53. PubMed ID: 3030424 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. Gutshall DM; Pilcher GD; Langley AE J Toxicol Environ Health; 1989; 28(1):53-65. PubMed ID: 2506363 [TBL] [Abstract][Full Text] [Related]
13. Hepatic protein pattern alterations following perfluorodecanoic acid exposure in rats. Witzmann FA; Parker DN Toxicol Lett; 1991 Jun; 57(1):29-36. PubMed ID: 2048159 [TBL] [Abstract][Full Text] [Related]
14. Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cyclase and beta-adrenergic receptors in spontaneously hypertensive rats. Bhalla RC; Sharma RV; Ramanathan S Biochim Biophys Acta; 1980 Nov; 632(4):497-506. PubMed ID: 6254574 [TBL] [Abstract][Full Text] [Related]
15. The influence of dietary lipid supplementation on cardiac beta-adrenergic receptor adenylate cyclase activity in the marmoset monkey. McMurchie EJ; Patten GS; McLennan PL; Charnock JS; Nestel PJ Biochim Biophys Acta; 1988 Jan; 937(2):347-58. PubMed ID: 2827774 [TBL] [Abstract][Full Text] [Related]
16. Phorbol 12-myristate 13-acetate induces beta-adrenergic receptor uncoupling and non-specific desensitization of adenylate cyclase in human mononuclear leukocytes. Meurs H; Kauffman HF; Timmermans A; van Amsterdam FT; Koëter GH; de Vries K Biochem Pharmacol; 1986 Dec; 35(23):4217-22. PubMed ID: 3024644 [TBL] [Abstract][Full Text] [Related]
17. Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver. Goecke-Flora CM; Wyman JF; Jarnot BM; Reo NV Chem Res Toxicol; 1995; 8(1):77-81. PubMed ID: 7703370 [TBL] [Abstract][Full Text] [Related]
18. The cardiac and brain microvessel adenylate cyclase system in deoxycorticosterone acetate-hypertensive rats. Schütz W; Steurer G; Tuisl E; Kraupp O J Cardiovasc Pharmacol; 1984; 6(2):325-30. PubMed ID: 6200723 [TBL] [Abstract][Full Text] [Related]
19. Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B Frawley RP; Smith M; Cesta MF; Hayes-Bouknight S; Blystone C; Kissling GE; Harris S; Germolec D J Immunotoxicol; 2018 Dec; 15(1):41-52. PubMed ID: 29514525 [TBL] [Abstract][Full Text] [Related]
20. A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy. Goecke CM; Jarnot BM; Reo NV Chem Res Toxicol; 1992; 5(4):512-9. PubMed ID: 1391617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]